Cargando…

Oral beta-lactam step down in bacteremic E. coli urinary tract infections

BACKGROUND: Literature is scarce regarding oral step down to beta-lactams in bacteremic urinary tract infections. Oral fluoroquinolones are an accepted and common step down for bacteremic urinary tract infections; however, their use is associated with mounting safety concerns. We compared clinical c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saad, Stephan, Mina, Neil, Lee, Colin, Afra, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576740/ https://www.ncbi.nlm.nih.gov/pubmed/33087051 http://dx.doi.org/10.1186/s12879-020-05498-2

Ejemplares similares

1689. Oral Beta-lactam Step Down in Bacteremic E. coli Urinary Tract Infections
por: Saad, Stephan, et al.
Publicado: (2020)

189. Outcomes of High-dose Oral Beta-lactam Step-down Therapy Compared to Alternative Oral Therapy for Bacteremic Urinary Tract Infections
por: Geyer, Abigail, et al.
Publicado: (2023)

The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study
por: Hansen, Bjørn Åsheim, et al.
Publicado: (2022)

Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia
por: Bai, Anthony D., et al.
Publicado: (2020)

277. Comparison of Oral Beta-Lactams and Fluoroquinolones for Step-Down in Uncomplicated Enterobacterales Blood Stream Infections
por: Ngo, Nichol, et al.
Publicado: (2020)

Prevalence of and factors associated with atypical presentation in bacteremic urinary tract infection
por: Komagamine, Junpei, et al.
Publicado: (2022)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

Sensitivity of the dipstick in detecting bacteremic urinary tract infections in elderly hospitalized patients
por: Shimoni, Zvi, et al.
Publicado: (2017)

The Utility of Repeat Blood Cultures for Bacteremic Urinary Tract Infections and Associated Durations of Therapy
por: Sayood, Sena, et al.
Publicado: (2017)

Atypical Presentation of Bacteremic Urinary Tract Infection in Older Patients: Frequency and Prognostic Impact
por: Laborde, Caroline, et al.
Publicado: (2021)

1114. Oral β-lactams for the Treatment of Escherichia coli Bacteremia Secondary to Complicated Urinary Tract Infections Including Pyelonephritis
por: Harrington, Nicole, et al.
Publicado: (2019)

965. The Efficacy of Oral Β-lactam Antibiotics as Step-down Therapy for Acute Pyelonephritis
por: Hobbs, Athena L V, et al.
Publicado: (2019)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

195. Intravenous to Oral Antibiotics Versus Intravenous Antibiotics: A Step-Up or a Step-Down for Extended Spectrum Beta-Lactamase Producing Urinary Tract Infections?
por: Gamble, Kelly C, et al.
Publicado: (2021)

86. Effect of Oral Fosfomycin Compared to the Intravenous Beta Lactam/Beta-Lactamase Inhibitor or Carbapenem in Step-down Treatment of Patients with Complicated Urinary Tract Infection due to Extended-Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae: A Multicenter, Open-label, Randomized Controlled, Non-inferiority Trial
por: Seo, Jun-won, et al.
Publicado: (2023)

Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
por: Geyer, Abigail C., et al.
Publicado: (2023)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains
por: Jaureguy, Françoise, et al.
Publicado: (2008)

Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy
por: Lee, Yi-Chien, et al.
Publicado: (2016)

1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)

Characterization of Beta-Lactam Resistome of Escherichia coli Causing Nosocomial Infections
por: Vázquez-López, Rosalino, et al.
Publicado: (2023)

Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study
por: Li, Fuxing, et al.
Publicado: (2023)

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )
por: ten Doesschate, Thijs, et al.
Publicado: (2021)

Clinical Outcome of Bacteremic Spontaneous Bacterial Peritonitis due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Pneumoniae
por: Kang, Cheol-In, et al.
Publicado: (2004)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae
por: Murphy, Mark E., et al.
Publicado: (2021)

1621. Novel Beta-lactam Beta-lactamase Inhibitors Against Alternative Antibiotics for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis Caused by Carbapenem-resistant Enterobacterales
por: Green, Bliss, et al.
Publicado: (2020)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

Bacteremic renal stone-associated urinary tract infection caused by nontypable Haemophilus influenzae: A rare invasive disease in an immunocompetent patient
por: Fujii, Masanao, et al.
Publicado: (2016)

Structural insight into YcbB-mediated beta-lactam resistance in Escherichia coli
por: Caveney, Nathanael A., et al.
Publicado: (2019)

Extraintestinal Pathogenic Escherichia coli: Beta-Lactam Antibiotic and Heavy Metal Resistance
por: Longhi, Catia, et al.
Publicado: (2022)

1193. Impact of Removing Extended-spectrum Beta Lactamase Status Labeling from Culture Reports on Carbapenem Use for Non-bacteremic Patients With Urinary Tract Infections: A Multi-hospital Assessment
por: Alvarado, Lourdes R Menendez, et al.
Publicado: (2023)

Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI)
por: Tverring, Jonas, et al.
Publicado: (2023)

Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
por: Metlay, Joshua P., et al.
Publicado: (2006)

Moraxella catarrhalis bacteremic pneumonia
por: Anezaki, Hiroki, et al.
Publicado: (2020)

Imaging in urinary tract infection: top-down or down-up?
por: Müller, Lil-Sofie Ording
Publicado: (2011)

Similar Strains of Coagulase-Negative Staphylococci Found in the Gastrointestinal Tract and Bloodstream of Bacteremic Neonates
por: Adeghate, Jennifer O., et al.
Publicado: (2020)

Susceptibility to β-lactams and quinolones of Enterobacteriaceae isolated from urinary tract infections in outpatients
por: Marchisio, Martín, et al.
Publicado: (2015)

1037. Effect of Oral Step-Down Therapy on Readmission Rates in Escherichia coli Bacteremia
por: Sessa, Julia, et al.
Publicado: (2018)

High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran
por: Afsharikhah, Saleh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_skc3nm1p5rre3094m6lvonmjj3